Mechanisms of Disease: astrocytes in neurodegenerative disease (original) (raw)

• Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1–105
  Article CAS Google Scholar
• Kofuji P and Newman EA (2004) Potassium buffering in the central nervous system. Neuroscience 129: 1045–1056
  Article CAS Google Scholar
• Hirase H (2005) A multi-photon window onto neuronal-glial-vascular communication. Trends Neurosci 28: 217–219
  Article CAS Google Scholar
• Takano T et al. (2006) Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9: 260–267
  Article CAS Google Scholar
• Chaudhry FA et al. (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15: 711–720
  Article CAS Google Scholar
• Lehre KP et al. (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15: 1835–1853
  Article CAS Google Scholar
• Milton ID et al. (1997) Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study. Mol Brain Res 52: 17–31
  Article CAS Google Scholar
• Rothstein JD et al. (1994) Localization of neuronal and glial glutamate transporters. Neuron 13: 713–725
  Article CAS Google Scholar
• Rothstein JD et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675–686
  Article CAS Google Scholar
• Tanaka K et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699–1702
  Article CAS Google Scholar
• Bezzi P et al. (2001) CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702–710
  Article CAS Google Scholar
• Haydon PG (2001) Glia: listening and talking to the synapse. Nat Rev Neurosci 2: 185–193
  Article CAS Google Scholar
• Ye ZC et al. (2003) Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 23: 3588–3596
  Article CAS Google Scholar
• Simard M and Nedergaard M (2004) The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129: 877–896
  Article CAS Google Scholar
• Pekny M (2001) Astrocytic intermediate filaments: lessons from GFAP and vimentin knock-out mice. Prog Brain Res 132: 23–30
  Article CAS Google Scholar
• Eng LF et al. (1998) Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. J Neurosci Res 53: 353–360
  Article CAS Google Scholar
• Wilhelmsson U et al. (2004) Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 24: 5016–5021
  Article CAS Google Scholar
• Tanaka K et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699–1702
  Article CAS Google Scholar
• Mitani A and Tanaka K (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 23: 7176–7182
  Article CAS Google Scholar
• Watanabe T et al. (1999) Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res 845: 92–96
  Article CAS Google Scholar
• Mallolas J et al. (2006) A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 203: 711–717
  Article CAS Google Scholar
• Sofroniew MV (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11: 400–407
  Article CAS Google Scholar
• Dermietzel R et al. (1991) Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11: 1421–1432
  Article CAS Google Scholar
• Reaume AG et al. (1995) Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831–1834
  Article CAS Google Scholar
• Siushansian R et al. (2001) Connexin43 null mutation increases infarct size after stroke. J Comp Neurol 440: 387–394
  Article CAS Google Scholar
• Patel SA and Maragakis NJ (2002) Amyotrophic lateral sclerosis: pathogenesis, differential diagnoses, and potential interventions. J Spinal Cord Med 25: 262–273
  Article Google Scholar
• Bristol LA and Rothstein JD (1996) Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 39: 676–679
  Article CAS Google Scholar
• Lin CL et al. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20: 589–602
  Article CAS Google Scholar
• Meyer T et al. (1999) The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J Neurol Sci 170: 45–50
  Article CAS Google Scholar
• Flowers JM et al. (2001) Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann Neurol 49: 643–649
  Article CAS Google Scholar
• Gurney ME et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772–1775
  Article CAS Google Scholar
• Wong PC et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105–1116
  Article CAS Google Scholar
• Bruijn LI et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18: 327–338
  Article CAS Google Scholar
• Howland DS et al. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 99: 1604–1609
  Article CAS Google Scholar
• Guo H et al. (2003) Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 12: 2519–2532
  Article CAS Google Scholar
• Clement AM et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113–117
  Article CAS Google Scholar
• Miller TM et al. (2005) Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol 57: 773–776
  Article CAS Google Scholar
• Ralph GS et al. (2005) Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 11: 429–433
  Article CAS Google Scholar
• Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741–766
  Article CAS Google Scholar
• Wisniewski HM and Wegiel J (1991) Spatial relationships between astrocytes and classical plaque components. Neurobiol Aging 12: 593–600
  Article CAS Google Scholar
• DeWitt DA et al. (1998) Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 149: 329–340
  Article CAS Google Scholar
• Nagele RG et al. (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25: 663–674
  Article CAS Google Scholar
• Haughey NJ and Mattson MP (2003) Alzheimer's amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes. Neuromolecular Med 3: 173–180
  Article Google Scholar
• Johnston JM et al. (2006) Calcium oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation. Neurosci Lett 395: 159–164
  Article CAS Google Scholar
• Feany MB and Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388–1396
  CAS PubMed PubMed Central Google Scholar
• Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9: 663–679
  Article CAS Google Scholar
• Forman MS et al. (2005) Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci 25: 3539–3550
  Article CAS Google Scholar
• Dabir DV et al. (2006) Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 26: 644–654
  Article CAS Google Scholar
• Hersch SM et al. (2004) In Neurologic Principles and Practice, 503–526 (Ed Koller W) New York: McGraw-Hill
  Google Scholar
• Singhrao SK et al. (1998) Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington's, Alzheimer's, and Pick's diseases. Exp Neurol 150: 213–222
  Article CAS Google Scholar
• Arzberger T et al. (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease—an in situ hybridization study. J Neuropathol Exp Neurol 56: 440–454
  Article CAS Google Scholar
• Rothstein JD et al. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326: 1464–1468
  Article CAS Google Scholar
• Vis JC et al. (1998) Connexin expression in Huntington's diseased human brain. Cell Biol Int 22: 837–847
  Article CAS Google Scholar
• Lievens JC et al. (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 8: 807–821
  Article CAS Google Scholar
• Behrens PF et al. (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125: 1908–1922
  Article CAS Google Scholar
• Shin JY et al. (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171: 1001–1012
  Article CAS Google Scholar
• Nutt JG and Wooten GF (2005) Clinical practice: diagnosis and initial management of Parkinson's disease. N Engl J Med 353: 1021–1027
  Article CAS Google Scholar
• Forno LS et al. (1992) Astrocytes and Parkinson's disease. Prog Brain Res 94: 429–436
  Article CAS Google Scholar
• Damier P et al. (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52: 1–6
  Article CAS Google Scholar
• Wakabayashi K et al. (2000) NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol (Berl) 99: 14–20
  Article CAS Google Scholar
• Teismann P and Schulz JB (2004) Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res 318: 149–161
  Article Google Scholar
• Saura J et al. (2003) Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity. J Neurochem 85: 651–661
  Article CAS Google Scholar
• Heales SJ et al. (2004) Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem Res 29: 513–519
  Article CAS Google Scholar
• Maragakis NJ and Rothstein JD (2004) Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 15: 461–473
  Article CAS Google Scholar
• Brenner M et al. (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27: 117–120
  Article CAS Google Scholar
• Li R et al. (2005) Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 57: 310–326
  Article Google Scholar
• Rothstein JD et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73–77
  Article CAS Google Scholar
• Watanabe M et al. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 8: 933–941
  Article CAS Google Scholar